Latest News

OMass Therapeutics Announces £27.5 Million Extended Series A Financing

17th February 2020

All News | Financial News | Spinouts & Startups

Developing a pipeline of small molecule therapeutics for patients with immunological and genetic disorders.

VR for mental health firm raises £12.5m

12th February 2020

All News | Financial News | Spinouts & Startups

Oxford Investment Opportunity Network and Oxford Angel Network join forces

23rd January 2020

All News | Financial News

Leading angel networks in Oxford merge to catalyse early-stage tech investment in the Oxford Cluster.

OrganOx liver transplant tech gets £4.6m boost

6th January 2020

All News | Financial News | Spinouts & Startups

Nanopore raises over £100m in latest round

2nd January 2020

All News | Financial News | Spinouts & Startups

Prolific plants $1.2m seed to take on Amazon’s online research market

4th December 2019

All News | Financial News | Spinouts & Startups

Y Combinator startup Prolific announces $1.2M seed round with participation from Pioneer Fund and prominent Silicon Valley Angel investors.

MiroBio launches with £27m Series A from leading life sciences investors

7th October 2019

All News | Financial News | Spinouts & Startups

Oxford spinout developing novel therapeutics based on deep expertise in immune cell regulation.

Oxford University Innovation Q2 2019 Update

23rd July 2019

All News | Financial News | Spinouts & Startups

LAB10x launched and AI@Oxford on the horizon in another active quarter for the Oxford Innovation Ecosystem.

Oxford University welcomes Osage University Partners to the Oxford innovation ecosystem

17th July 2019

All News | Financial News

Osage University Partners and Oxford University Innovation sign MoU on investment into Oxford University spinouts.

Image from Oxford University, Sensyne Health, Evotec, and OSI create new partnership called LAB10x to accelerate data-driven drug discovery powered by AI News Article

Oxford University, Sensyne Health, Evotec, and OSI create new partnership called LAB10x to accelerate data-driven drug discovery powered by AI

24th June 2019

All News | Financial News

LAB10x aims to accelerate the commercialisation of the next generation of digital therapeutics and data-driven drug discovery from clinical artificial intelligence research and digital health innovations at Oxford University

News

Ready to get in touch?